- Moderna and IBM announced their intentions to explore technologies, including artificial intelligence, blockchain and hybrid cloud, that could help support smarter COVID-19 vaccine management. Central to the effort will be a pilot of open, standardized, technology-enabled vaccine distribution approaches aimed to improve supply chain visibility and foster near real-time tracking of vaccine administration.
- The goal of the partnership is to identify ways technology can be used to help accelerate secure, information sharing between governments, healthcare providers, life science organizations and individuals. In so doing, Moderna and IBM seek to improve confidence in vaccine programs and increase rates of vaccination, thereby reducing community spread.
COVID-19 Vaccine Supply Chain and Distribution Data Sharing
Initial work is planned to focus on exploring the utility of IBM capabilities in the U.S. including:
– Vaccine management solutions that provide end-to-end traceability to address potential supply chain disruptions. The solutions enable governments and healthcare providers to quickly and securely share data regarding individual vaccine batches as they travel through the complex COVID-19 supply chain, from manufacturing facilities to administration sites.
– Digital Health Pass, built on blockchain technology, is a solution designed to help individuals maintain control of their personal health information and share it in a way that is secured, verifiable and trusted. Organizations can use the solution to verify health credentials for employees, customers and travelers based on criteria specified by the organization, such as test results, vaccination records and temperature checks.
Source: Hit Consultant
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
